Eagle Asset Management’s Eterna Therapeutics ERNA Stock Holding History

Eagle Asset Management’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10	Closed	-$17K	–	541
2022 Q3	$17K	Hold	10	–	–	﹤0.01%	542
2022 Q2	$37K	Hold	10	–	–	﹤0.01%	556
2022 Q1	$147K	Buy	+10	New	+$190K	﹤0.01%	564
2021 Q4	–	Sell	-17	Closed	-$1.22M	–	607
2021 Q3	$1.22M	Buy	17 +1	+6%	+$86.3K	0.01%	508
2021 Q2	$2.14M	Buy	16 +10	+167%	+$1.44M	0.01%	478
2021 Q1	$175K	Buy	6 +1	+20%	+$54.2K	﹤0.01%	582
2020 Q4	$157K	Buy	+5	New	+$152K	﹤0.01%	519
2018 Q4	–	Sell	-5	Closed	-$320K	–	607
2018 Q3	$320K	Hold	5	–	–	﹤0.01%	593
2018 Q2	$319K	Hold	5	–	–	﹤0.01%	598
2018 Q1	$489K	Hold	5	–	–	﹤0.01%	586
2017 Q4	$302K	Sell	5 -1	-17%	-$79K	﹤0.01%	608
2017 Q3	$552K	Hold	6	–	–	﹤0.01%	570
2017 Q2	$613K	Hold	6	–	–	﹤0.01%	585
2017 Q1	$775K	Hold	6	–	–	﹤0.01%	598
2016 Q4	$766K	Hold	6	–	–	0.01%	595
2016 Q3	$640K	Hold	6	–	–	﹤0.01%	598
2016 Q2	$775K	Hold	6	–	–	0.01%	601
2016 Q1	$672K	Hold	6	–	–	﹤0.01%	593
2015 Q4	$737K	Hold	6	–	–	﹤0.01%	597
2015 Q3	$1.54M	Hold	6	–	–	0.01%	581
2015 Q2	$1.07M	Hold	6	–	–	0.01%	610
2015 Q1	$1.76M	Hold	6	–	–	0.01%	566
2014 Q4	$1.86M	Hold	6	–	–	0.01%	555
2014 Q3	$1.38M	Hold	6	–	–	0.01%	605
2014 Q2	$2.19M	Buy	6 +1	+20%	+$440K	0.01%	587
2014 Q1	$2.27M	Hold	5	–	–	0.01%	603
2013 Q4	$2.17M	Buy	5 +1	+25%	+$437K	0.01%	580
2013 Q3	$1.03M	Hold	4	–	–	0.01%	668
2013 Q2	$1.17M	Buy	+4	New	+$1.05M	0.01%	648

Other funds holding ERNA

Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

CPWM

Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Eagle Asset Management's ERNA Position: Q4 2022 in Review

Eagle Asset Management sold out of Eterna Therapeutics (ERNA) in Q4 2022, closing a stake of 10 shares — an estimated $17K sold.

Eagle Asset Management first reported a position in ERNA in Q2 2013 and held it in 29 quarters. The position peaked at $2.27M in Q1 2014. 11 funds tracked by Wall St. Rank hold ERNA as of Q4 2022.

Eagle Asset Management reported no remaining Eterna Therapeutics position as of Q4 2022 after selling out during the quarter.
Eagle Asset Management sold 10 Eterna Therapeutics shares in Q4 2022, an estimated $17K.
Eagle Asset Management first reported a position in Eterna Therapeutics in Q2 2013 and held it in 29 quarters.
Eagle Asset Management's Eterna Therapeutics position peaked at $2.27M in Q1 2014.
11 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2022.

Based on Eagle Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.